Wk 21 Assign
docx
keyboard_arrow_up
School
University Of Arizona *
*We aren’t endorsed by this school
Course
415
Subject
Philosophy
Date
Dec 6, 2023
Type
docx
Pages
4
Uploaded by ChiefBook8300
Case Analysis: Sycamore Pharmaceuticals
Case Analysis: Sycamore Pharmaceuticals
Crystal Moon
ABS 415: Leadership & Ethics in a Changing World
Instructor: Ken Feifer
10/30/2023
1
Case Analysis: Sycamore Pharmaceuticals
Introduction
In Sycamore Pharmaceuticals' case analysis, employee John Blake knew that he might
take a risk by encouraging his medication without scientific study in order to support claims of
its success. Sycamore Pharmaceuticals suppressed the knowledge of the medicine osteoporin,
which is used for the treatment of Crohn's disease and lupus. Sycamore Pharmaceuticals has
instructed its personnel not to disclose anything negative about the medicine to anyone. When
the FDA representative wanted to talk to him about his knowledge of Osteoporin's scientific
studies, without hesitation, John Blake was in a difficult position. John's worried that he would
have failed to gain an important incentive and employment with Sycamore Pharmaceuticals if he
hadn't told the truth. Whether or not John should be truthful to the FDA, the bravery he's shown,
and why Dominguez and Blake have been so dishonest in the first place, will be covered in this
article.
I'd first advise John Blake to behave honestly with the FDA because honesty is always
your best bet. I personally believe that dishonesties and secrets lead to more deception and
secrets and the truth will be revealed whether we like it or not. It's obvious to me why John
would consider lying to the Food and Drug Administration. However, we are considered to be
less competent if our behavior produces good results and if we fail to achieve the expected
results, Irwin, T., 2014 In the present case, the revelation of the truth would result in a bad
outcome for the medicine and Sycamore Pharmaceuticals. He might lose his job and lose his
incentive, if he's honest, because the medicine would be removed from the market. He could be
in trouble with the FDA even after his medicine has been marketed knowing there is a risk of
adverse reactions. If John were to be true, then the issue that would arise is more important than
what might come out of it if he kept lying. John must consider the risk to those taking the
2
Case Analysis: Sycamore Pharmaceuticals
medicine because they are not aware of the adverse effects, his best bet was to be honest. Patients
were paying for a medicine that was not likely to be effective and could have serious side effects.
It can be a satisfying thing to know that you've been honest, especially if it means saving
someone's life. John's fear was that he'd lose his incentive and his position, but being dishonest
as a leader is not the way to do it. It's in his hands and in his mind, because you're what you think
you are, and your self-image determines your performance, (B.Tracy, 2014).Trust goes a long
way, if he would be truthful his fellow employees would follow suit and also show admiration
towards him.
John has to be courageous in exposing the scientific studies' purpose and content. Not
only is John in danger of losing his job or being demoted to a different position, he's putting the
company and its associates at serious risk by doing so. To benefit John, he needs to find courage
to be honest, he must find his try courage and specifically tell courage. In order to be courageous,
one must not play it safe but act and do what is right and this will allow John the opportunity to
acknowledge his mistakes and learn from them so that he's able to find a way forward with any
remaining obstacles (Daft, R, 2014). Telling courage is a verbal way of being truthful, declaring
beliefs, and point out wrong doings (Daft, R, 2014). John's going to take the responsibility for
telling the truth to the FDA, and he’ll be brave enough to admit it.
3
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
- Access to all documents
- Unlimited textbook solutions
- 24/7 expert homework help
Case Analysis: Sycamore Pharmaceuticals
References
Daft, R. L. (2014).The Leadership Experience(6thed.). Mason, OH: Cengage Learning:
ISBN:9781435462854
Irwin, T. (2014).Impact: Great Leadership Changes Everything.Dallas, US: BenBella
Books.Retrieved fromhttp://site.ebrary.com.proxy-
library.ashford.edu/lib/ashford/reader.action?docID=10839051&ppg=30
4